Report overview
The global Active Pharmaceutical Ingredients (API) CDMO market was valued at US$ million in 2023 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2023, While China is to reach $ Million.
Macromolecular API Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Active Pharmaceutical Ingredients (API) CDMO include Recipharm, Cambrex Corporation, Patheon (Thermo Fisher Scientific), CordenPharma, Lonza, Siegfried, Catalent, Boehringer Ingelheim and Piramal Group, etc. in 2023, the global top five players have a share approximately % in terms of revenue.
This report aims to provide a comprehensive presentation of the global market for Active Pharmaceutical Ingredients (API) CDMO, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Active Pharmaceutical Ingredients (API) CDMO. This report contains market size and forecasts of Active Pharmaceutical Ingredients (API) CDMO in global, including the following market information:
Global Active Pharmaceutical Ingredients (API) CDMO Market Revenue, 2019-2024, 2025-2030, ($ millions)
Global top five companies in 2023 (%)
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Active Pharmaceutical Ingredients (API) CDMO companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Active Pharmaceutical Ingredients (API) CDMO Market, by Type, 2019-2024, 2025-2030 ($ millions)
Global Active Pharmaceutical Ingredients (API) CDMO Market Segment Percentages, by Type, 2023 (%)
Macromolecular API
Small Molecule API
Global Active Pharmaceutical Ingredients (API) CDMO Market, by Application, 2019-2024, 2025-2030 ($ millions)
Global Active Pharmaceutical Ingredients (API) CDMO Market Segment Percentages, by Application, 2023 (%)
Clinical
Commercial
Others
Global Active Pharmaceutical Ingredients (API) CDMO Market, By Region and Country, 2019-2024, 2025-2030 ($ Millions)
Global Active Pharmaceutical Ingredients (API) CDMO Market Segment Percentages, By Region and Country, 2023 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Active Pharmaceutical Ingredients (API) CDMO revenues in global market, 2019-2024 (estimated), ($ millions)
Key companies Active Pharmaceutical Ingredients (API) CDMO revenues share in global market, 2023 (%)
Further, the report presents profiles of competitors in the market, key players include:
Recipharm
Cambrex Corporation
Patheon (Thermo Fisher Scientific)
CordenPharma
Lonza
Siegfried
Catalent
Boehringer Ingelheim
Piramal Group
AbbVie
SGS Quay Pharmaceuticals
Aenova Group
Curia
Sterling Pharma Solutions
Eurofins CDMO
Outline of Major Chapters:
Chapter 1: Introduces the definition of Active Pharmaceutical Ingredients (API) CDMO, market overview.
Chapter 2: Global Active Pharmaceutical Ingredients (API) CDMO market size in revenue.
Chapter 3: Detailed analysis of Active Pharmaceutical Ingredients (API) CDMO company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Active Pharmaceutical Ingredients (API) CDMO in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
